Prognostic significance of RIN1 gene expression in human non-small cell lung cancer

Acta Histochemica

Volumn 114, Issue 5, 2012, Pages 463-468

  Wang, Qun ^a   Gao, Ying ^a   Tang, Yufu ^a   Ma, Lie ^a   Zhao, Mingjing ^a   Wang, Xiaoge ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Human; Non small cell lung carcinoma; Prognosis; RIN1

Indexed keywords

MESSENGER RNA; RAS AND RAB INTERACTOR 1 PROTEIN; REGULATOR PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAS AND RAB INTERACTOR 1 GENE; REGULATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84860379468     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2011.08.008     Document Type: Article

References (22)

1. Afar D.E., Han L., McLaughlin J., Wong S., Dhaka A., Parmar K., et al. Regulation of the oncogenic activity of BCR-ABL by a tightly bound substrate protein RIN1. Immunity 1997, 6:773-782.
2. Barbieri M.A., Kong C., Chen P.I., Horazdovsky B.F., Stahl P.D. The SRC homology 2 domain of Rin1 mediates its binding to the epidermal growth factor receptor and regulates receptor endocytosis. J Biol Chem 2003, 278:32027-32036.
3. Chetcuti A., Aktas S., Mackie N., Ulger C., Toruner G., Alkan M., et al. Expression profiling reveals MSX1 and EphB2 expression correlates with the invasion capacity of Wilms tumors. Pediatr Blood Cancer 2011, 10.1002/pbc.23003. [Epub ahead of print].
4. Deininger K., Eder M., Kramer E.R., Zieglgansberger W., Dodt H.U., Dornmair K., et al. The Rab5 guanylate exchange factor Rin1 regulates endocytosis of the EphA4 receptor in mature excitatory neurons. Proc Natl Acad Sci USA 2008, 105:12539-12544.
5. Dhaka A., Costa R.M., Hu H., Irvin D.K., Patel A., Kornblum H.I., et al. The RAS effector RIN1 modulates the formation of aversive memories. J Neurosci 2003, 23:748-757.
6. Goi T., Senda K., Yamaguchi A. Expression of RIN1 gene in gastric and colorectal cancers. Nippon Geka Gakkai Zasshi 2001, 102:783.
7. Han L., Wong D., Dhaka A., Afar D., White M., Xie W., et al. Protein binding and signaling properties of RIN1 suggest a unique effector function. Proc Natl Acad Sci USA 1997, 94:4954-4959.
8. Hu H., Bliss J.M., Wang Y., Colicelli J. RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration. Curr Biol 2005, 15:815-823.
9. Hu H., Milstein M., Bliss J.M., Thai M., Malhotra G., Huynh L.C., et al. Integration of transforming growth factor beta and RAS signaling silences a RAB5 guanine nucleotide exchange factor and enhances growth factor-directed cell migration. Mol Cell Biol 2008, 28:1573-1583.
10. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96.
11. Kamangar F., Dores G.M., Anderson W.F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006, 24:2137-2150.
12. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
13. Milstein M., Mooser C.K., Hu H., Fejzo M., Slamon D., Goodglick L., et al. RIN1 is a breast tumor suppressor gene. Cancer Res 2007, 67:11510-11516.
14. Morikawa J., Li H., Kim S., Nishi K., Ueno S., Suh E., et al. Identification of signature genes by microarray for acute myeloid leukemia without maturation and acute promyelocytic leukemia with t(15;17)(q22;q12)(PML/RARalpha). Int J Oncol 2003, 23:617-625.
15. Senda K., Goi T., Hirono Y., Katayama K., Yamaguchi A. Analysis of RIN1 gene expression in colorectal cancer. Oncol Rep 2007, 17:1171-1175.
16. Shuster M.I., Han L., Le Beau M.M., Davis E., Sawicki M., Lese C.M., et al. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification. Genes Chromosomes Cancer 2000, 28:153-163.
17. Sobin L.H., Fleming I.D. TNM classification of malignant tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997, 80:1803-1804.
18. Tall G.G., Barbieri M.A., Stahl P.D., Horazdovsky B.F. Ras-activated endocytosis is mediated by the Rab5 guanine nucleotide exchange activity of RIN1. Dev Cell 2001, 1:73-82.
19. Tomshine J.C., Severson S.R., Wigle D.A., Sun Z., Beleford D.A., Shridhar V., et al. Cell proliferation and epidermal growth factor signaling in non-small cell lung adenocarcinoma cell lines are dependent on Rin1. J Biol Chem 2009, 284:26331-26339.
20. Wang Y., Waldron R.T., Dhaka A., Patel A., Riley M.M., Rozengurt E., et al. The RAS effector RIN1 directly competes with RAF and is regulated by 14-3-3 proteins. Mol Cell Biol 2002, 22:916-926.
21. Zainabadi K., Benyamini P., Chakrabarti R., Veena M.S., Chandrasekharappa S.C., Gatti R.A., et al. A 700-kb physical and transcription map of the cervical cancer tumor suppressor gene locus on chromosome 11q13. Genomics 2005, 85:704-714.
22. Ziegler S., Eiseler T., Scholz R.P., Beck A., Link G., Hausser A. A novel protein kinase D phosphorylation site in the tumor suppressor Rab interactor 1 is critical for coordination of cell migration. Mol Biol Cell 2011, 22:570-580.